EBITDA: Income before interest, taxes, depreciation and amortization.
Biora Therapeutics, Inc. (BIORQ) had EBITDA of $-15.18M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$0.03M |
|
$-18.40M |
|
-- |
|
$0.03M |
|
$16.26M |
|
$-16.23M |
|
$-6.04M |
|
$-22.26M |
|
$-22.26M |
|
$-22.22M |
|
$-22.22M |
|
$-18.40M |
|
$-22.22M |
|
$-16.23M |
|
|
EBITDA |
$-15.18M |
36.53M |
|
36.53M |
|
$-5.04 |
|
$-5.04 |
|
| Balance Sheet Financials | |
$6.05M |
|
$1.18M |
|
$8.45M |
|
$14.51M |
|
$120.62M |
|
-- |
|
$0.52M |
|
$121.13M |
|
$-106.63M |
|
$-112.70M |
|
$-106.63M |
|
3.68M |
|
| Cash Flow Statement Financials | |
$-32.18M |
|
$2.81M |
|
$17.36M |
|
$15.21M |
|
$3.20M |
|
$-12.02M |
|
$4.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.36 |
|
100.00% |
|
-50709.38% |
|
-50709.38% |
|
-- |
|
-69568.74% |
|
-57506.25% |
|
$-32.37M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.04 |
|
2441.25 |
|
20.84% |
|
19.71% |
|
-153.17% |
|
20.84% |
|
$-28.99 |
|
$-0.89 |
|
$-0.88 |
|